Kimura T, Katakura Y, Shimoda M, Kawasaki F, et al. Comparison of clinical efficacy and safety of weekly glucagon-like peptide-1 receptor agonists dulaglutide and semaglutide in Japanese patients with type 2 diabetes: Randomized, parallel-group, multicentre, open-label trial (COMING study). Diabetes Obes Metab 2023 Aug 30. doi: 10.1111/dom.15258.
PMID: 37646192